phenindione (Q1640947)

phenindione (English)

3 October 2016

chemical formula

C₁₅H₁₀O₂

1 reference

phenindione (English)

19 November 2016

canonical SMILES

C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O

1 reference

phenindione (English)

https://www.whocc.no/atc_ddd_index/?code=B01AA02

19 November 2016

defined daily dose

0.1 gram

route of administration

oral administration

1 reference

reference URL

World Health Organisation international non-proprietary name

phenindione (English)

1 reference

phenindione (English)

significant drug interaction

3 October 2016

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

urokinase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alteplase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenecteplase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Streptokinase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

iloprost

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prostacyclin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prasugrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cangrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Vitamin K epoxide reductase complex subunit 1

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

6838

Vitamin K epoxide reductase complex subunit 1

17 August 2016

subject has role

reaction inhibitor

1 reference

Open Targets Platform

https://platform.opentargets.org/drug/CHEMBL711

14 August 2023

reference URL

pregnancy category

Australian pregnancy category D

1 reference

imported from Wikimedia project

1 reference

Medical Subject Headings

15 March 2018

Phenindione

0 references

Identifiers

InChI

InChI=1S/C15H10O2/c16-14-11-8-4-5-9-12(11)15(17)13(14)10-6-2-1-3-7-10/h1-9,13H

1 reference

phenindione (English)

19 November 2016

2 references

phenindione (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

83-12-5

2 references

phenindione (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=83-12-5

10 April 2021

1 reference

Phenindione (English)

3 October 2016

2 references

phenindione (English)

19 November 2016

Reaxys registry number

1911699

1 reference

phenindione (English)

3 October 2016

ChEBI ID

8066

mapping relation type

2 references

PHENINDIONE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C15H10O2/c16-14-11-8-4-5-9-12(11)15(17)13(14)10-6-2-1-3-7-10/h1-9,13H

1 reference

PHENINDIONE (English)

19 November 2016

2 references

inferred from InChIKey

splash10-00di-4690000000-3b0da30c88d7d0ecf339

1 reference

MassBank accession ID

MSBNK-Waters-WA000340

0 references

MSBNK-Waters-WA000341

0 references

MSBNK-Waters-WA000342

0 references

MSBNK-Waters-WA000343

0 references

MSBNK-Waters-WA000344

0 references

MSBNK-Waters-WA000345

0 references

MSBNK-Waters-WA000346

0 references

MSBNK-Waters-WA000347

0 references

MSBNK-Waters-WA000348

0 references

SPLASH

0 references

NMRShiftDB structure ID

10023100

1 reference

HSDB ID

3155

1 reference

Hazardous Substances Data Bank

28 October 2019

PHENINDIONE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

phenindione (English)

ECHA Substance Infocard ID

19 November 2016

100.001.323

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.001.323

27 December 2018

Phenindione (English)

quotation

CAS no.: 83-12-5 (English)

1 reference

Guide to Pharmacology Ligand ID

Phenindione (English)

publication date

17 November 2015

6838

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

6838

D02.455.426.559.847.486.487.750

phenindione (English)

19 November 2016

Phenindione

0 references

MeSH concept ID

M0016509

0 references

MeSH tree code

0 references

0 references

1 reference

phenindione (English)

19 November 2016

DrugBank ID

DB00498

1 reference

Human Metabolome Database ID

HMDB0014641

2 references

based on heuristic

inferred from InChIKey

2 references

phenindione (English)

19 November 2016

0 references

1 reference

1 reference

phenindione (English)

3 October 2016

1 reference